Brickell Biotech is a pharmaceutical company that develops prescription therapeutics for autoimmune, inflammatory, and debilitating diseases in the US. The company has various products in the pipeline, including sofpironium bromide for axillary hyperhidrosis, BBI-02 for autoimmune and inflammatory diseases, and BBI-10 for rare genetic diseases. Brickell Biotech has collaborated with multiple organizations for licensing, including Carna Biosciences, Inc. Voronoi Inc., Bodor Laboratories, and Dr. Nicholas S. Bodor, and AnGes, Inc.